METFORMIN FOR ATRIAL FIBRILLATION
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 770 participants.
Also called NCT05878535
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 770 participants
- Sponsor
- Arab Contractors Medical Centre
- Registry
-
NCT05878535
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Unknown status
Technical summary
Registry record NCT05878535. Randomized; no masking; primary purpose treatment. Start 2024-06-01 (anticipated); primary completion 2025-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- METFORMIN FOR ATRIAL FIBRILLATION
- Acronym
- MAFT
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Metformin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Arab Contractors Medical Centre
Record details
- Record id
cardio:ct-nct05878535- Content hash
187991176ebb9552666433e241149cc82837c582bc2f2dae20232182f025d7f0